Hello, Fool! | Login | Signup | My Fool
Dec 3, 2008 11:45 PM ET | Feedback | Site Changes | Help
Choose a Broker | Fool's Two Top Stocks
Home > Investing > Dividends & Income
Sponsored By
By Mac Greer July 31, 2008 | Comments (1)
Recs
It’s been a bad year for banks and brokerages. So are there some bargains out there for investors? In this installment of "Fool Video," online managing editor LouAnn DiCosmo talks with senior analyst James Early. James gives his take on Banco Bilbao Vizcaya Argentaria (NYSE: BBV), Bank of America (NYSE: BAC), CapitalSource (NYSE: CSE), Citigroup (NYSE: C), JPMorgan Chase (NYSE: JPM), Lehman Brothers (NYSE: LEH) and National Bank of Greece (NYSE: NBG).
Please enable JavaScript to view this video.
And check out some of our other Fool Fare:
Banco Bilbao Vizcaya Argentaria, Bank of America, Capital Source, JP Morgan Chase, and National Bank of Greece are Motley Fool Income Investor recommendations. The Motley Fool owns shares of Capital Source. Neither James nor Lou nor Mac owns shares of any of the stocks discussed. The Fool has a disclosure policy.
Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.
I wonder if Wachovia will ever be the bank it once was?
Javascript is required to comment on Fool articles.
DocumentId: 697456, ~/articles/articlehandler.aspx, 12/3/2008 11:45:28 PM,
Signing up allows you to comment on articles and on the discussion boards.
Already registered? Login Here
We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement
Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.
CAPS Rating 3/5 Stars
$15.05
+1.00 (+7.12%)
Outperform6224
Underperform857
All stories about BAC